Company intelligence / Profile preview
iCELL Biotechnology
Shanghai, Shanghai, Chinaicell.com.cn ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Founded in 2010 and based in Hongqiao, Shanghai, iCELL Biotechnology specializes in research and development of innovative cell-based medicines and novel drugs. The company has been recognized nationally for its innovation capabilities but specific clinical results are not detailed publicly[3].
- Modalities
- Cell therapiesAdvanced biologicsGene/cell-based products
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Beyond the preview
Go deeper on iCELL Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on iCELL Biotechnology.